ATYR
aTyr Pharma, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
aTyr Pharma (ATYR) Stock: Buy, Sell, or Hold?
$4.96
-0.28 (-5.34%)
▼
5d:
-34.39%
30d:
+2788.76%
90d:
+830.93%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 05, 2026
Updated Nov 16, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
33/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.12 – $6.21
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$45.17
+762.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.70 / $7.98
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ATYR is down 34.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ATYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ATYR is currently trading at $4.96, which is considered slightly high relative to its 30-day fair value range of $0.12 to $6.21.
Technical Outlook: Technically, ATYR is in a uptrend. Immediate support is located at $4.70, while resistance sits at $7.98. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ATYR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.17 (+762.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATYR is in a uptrend. Immediate support is located at $4.70, while resistance sits at $7.98. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ATYR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.17 (+762.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.12 -
$6.21
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$0.12 -
$6.21
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$4.70
Resistance Level
$7.98
Current Trend
Uptrend
Technical data as of
Nov 17, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Technical Setup Structure
MONITORING
Absorption:
Inactive (CMF 0.34)
Pullback / Drawdown:
-30.9% from 52W High
Consolidation:
Trending (ADX 64.7)
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 762.0% below Wall St target ($45.17)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.05
Wall Street Target
$45.17
(+762.0%)
Share ATYR Analysis
Share this live ATYR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ATYR)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 14, 2026
Daily AI digest
AI Retail Discussion Summary:
Moderna's international revenue reached $900 million in the first nine months of 2026, making up about 40% of third-quarter revenue. Moderna earned an operating profit in the third quarter of 2026, but still lost money on operations over the last twelve months.
Key Retail Themes:
International revenue growth
Profitability
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 2:26 PM ET
Data refreshes hourly during market hours. Next update: 3:26 PM
Data refreshes hourly during market hours. Next update: 3:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 56 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ATYR Research Pages
ATYR Technical Chart
ATYR Price Prediction
ATYR Intrinsic Value DCF
ATYR Earnings Date
Why is ATYR Moving Today?
ATYR Investment Advisor
ATYR Fair Price Analyzer
ATYR Target Price Playground
ATYR 5-Day Options Simulator
ATYR LEAP Simulator
ATYR Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
ATYR Competitors
Part B: Tradestie Flagship Market Scanners